Engineering IL-2 for immunotherapy of autoimmunity and cancer

R Hernandez, J Põder, KM LaPorte… - Nature Reviews …, 2022 - nature.com
Preclinical studies of the T cell growth factor activity of IL-2 resulted in this cytokine
becoming the first immunotherapy to be approved nearly 30 years ago by the US Food and …

The immune response in multiple sclerosis

S Rodríguez Murúa, MF Farez… - Annual Review of …, 2022 - annualreviews.org
Multiple sclerosis (MS) is a chronic autoimmune, inflammatory, and neurodegenerative
disease that affects the central nervous system (CNS). MS is characterized by immune …

[HTML][HTML] The role of natural killer cells in autoimmune diseases

UC Kucuksezer, E Aktas Cetin, F Esen… - Frontiers in …, 2021 - frontiersin.org
Natural killer (NK) cells, the large granular lymphocytes differentiated from the common
lymphoid progenitors, were discovered in early 1970's. They are members of innate …

[HTML][HTML] Multiple sclerosis: mechanisms and immunotherapy

C Baecher-Allan, BJ Kaskow, HL Weiner - Neuron, 2018 - cell.com
Multiple sclerosis (MS) is an autoimmune disease triggered by environmental factors that act
on a genetically susceptible host. It features three clinical stages: a pre-clinical stage …

Reassessing B cell contributions in multiple sclerosis

R Li, KR Patterson, A Bar-Or - Nature immunology, 2018 - nature.com
There is growing recognition that B cell contributions to normal immune responses extend
well beyond their potential to become antibody-producing cells, including roles at the innate …

[HTML][HTML] The IL-2–IL-2 receptor pathway in health and disease: The role of the soluble IL-2 receptor

J Damoiseaux - Clinical Immunology, 2020 - Elsevier
Abstract The interleukin (IL)-2–IL-2 receptor (IL-2R) pathway is important in immunity, but is
also involved in maintenance of self-tolerance. This paradox is further complicated by …

Multiple sclerosis: Pathology, diagnosis and treatments

WJ Huang, WW Chen, X Zhang - Experimental and …, 2017 - spandidos-publications.com
Multiple sclerosis (MS) is a complex neurodegenerative disease affecting the central
nervous system (CNS). The onset of MS has been typically observed in individuals aged …

[HTML][HTML] Recent advances in marine algae polysaccharides: Isolation, structure, and activities

SY Xu, X Huang, KL Cheong - Marine Drugs, 2017 - mdpi.com
Marine algae have attracted a great deal of interest as excellent sources of nutrients.
Polysaccharides are the main components in marine algae, hence a great deal of attention …

Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy

RA Morgan, N Chinnasamy, D Abate-Daga… - Journal of …, 2013 - journals.lww.com
Nine cancer patients were treated with adoptive cell therapy using autologous anti-MAGE-
A3 T-cell receptors (TCR)-engineered T cells. Five patients experienced clinical regression …

The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment

AP Robinson, CT Harp, A Noronha, SD Miller - Handbook of clinical …, 2014 - Elsevier
While no single model can exactly recapitulate all aspects of multiple sclerosis (MS), animal
models are essential in understanding the induction and pathogenesis of the disease and to …